<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000999'>Pyoderma</z:hpo> gangrenosum (PG) is an immune-mediated inflammatory skin condition representing one of the most distinct extraintestinal manifestations of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) </plain></SENT>
<SENT sid="1" pm="."><plain>PG occurs independently from <z:e sem="disease" ids="C0021831" disease_type="Disease or Syndrome" abbrv="">intestinal disease</z:e> activity in about 1-2% of patients suffering from <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> or <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and is characterized by <z:hpo ids='HP_0011010'>chronic</z:hpo> deep <z:hpo ids='HP_0200042'>skin ulcers</z:hpo> whose exact pathogenesis is still unknown </plain></SENT>
<SENT sid="2" pm="."><plain>So far, patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> have only been reported to develop PG during the course of IBD but not at the initial manifestation of bowel symptoms </plain></SENT>
<SENT sid="3" pm="."><plain>This is the first report demonstrating the simultaneous <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and severe multifocal PG </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, we provide first evidence that infliximab may have a particularly powerful effect in early disseminated PG compared to <z:hpo ids='HP_0003584'>late-onset</z:hpo> PG, advocating an early application of this drug </plain></SENT>
</text></document>